Literature DB >> 5929758

Bacteriophage infecting the myxobacterium Chondrococcus columnaris.

D T Kingsbury, E J Ordal.   

Abstract

Kingsbury, David T. (University of Washington, Seattle), and Erling J. Ordal. Bacteriophage infecting the myxobacterium Chondrococcus columnaris. J. Bacteriol. 91:1327-1332. 1966.-During a series of screening experiments, seven bacteriophages which infect the pathogenic myxobacterium Chondrococcus columnaris were isolated. Of these, one was chosen for detailed study. This phage has a wide host range among strains of C. columnaris, but does not infect other myxobacterial species tested. Morphologically, this phage resembles coliphage T2, though it is smaller. It has a head diameter of 600 A, a tail length of 1,000 A, and a tail width of 200 A. The head is attached to the tail by a well-defined neck. The turbid plaques produced by this phage are similar in appearance to those produced by coliphage lambda, and average 1 mm in diameter. The phage has a latent period of 100 min, a rise period of an additional 90 min, and a burst size of 23. Calcium ions at a concentration of 0.004 m are required for adsorption. This requirement cannot be met by substitution of magnesium ions. A purified preparation of 2 x 10(12) phage particles was extracted with phenol, and the nucleic acid was identified as deoxyribonucleic acid (DNA). Base ratios of the phage DNA and the DNA of two propagating strains were similar. Streptomycin at a concentration of 70 mug/ml inhibits phage infection at an early stage, probably by inhibiting injection of the phage DNA.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5929758      PMCID: PMC316032          DOI: 10.1128/jb.91.3.1327-1332.1966

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  15 in total

1.  Studies on the myxobacterium Chondrococcus columnaris. I. Serological typing.

Authors:  R L ANACKER; E J ORDAL
Journal:  J Bacteriol       Date:  1959-07       Impact factor: 3.490

2.  ACTION OF STREPTOMYCIN AND RELATED ANTIBIOTICS.

Authors:  T D BROCK
Journal:  Fed Proc       Date:  1964 Sep-Oct

3.  Study of a bacteriophage infecting the myxobacterium Chondrococcus columnaris.

Authors:  R L ANACKER; E J ORDAL
Journal:  J Bacteriol       Date:  1955-12       Impact factor: 3.490

4.  Lysogenicity and immunity to Bacillus phage W.

Authors:  E W McCLOY
Journal:  J Gen Microbiol       Date:  1958-02

5.  Infectivity of ribonucleic acid from tobacco mosaic virus.

Authors:  A GIERER; G SCHRAMM
Journal:  Nature       Date:  1956-04-14       Impact factor: 49.962

6.  Mutagens and infectious nucleic acids.

Authors:  J H NORTHROP; F CAVALLERO
Journal:  Proc Natl Acad Sci U S A       Date:  1961-10-15       Impact factor: 11.205

7.  A Bacteriophagelike Principle for Pseudomonas pyocyanea (Pseudomonas aeruginosa).

Authors:  L B Fastier
Journal:  J Bacteriol       Date:  1945-06       Impact factor: 3.490

8.  STREPTOMYCIN AS AN ANTIVIRAL AGENT: MODE OF ACTION.

Authors:  T D BROCK; S O WOOLEY
Journal:  Science       Date:  1963-09-13       Impact factor: 47.728

9.  NUTRITIONAL STUDIES ON THE "AUTO-PLAQUE" PHENOMENON IN PSEUDOMONAS AERUGINOSA.

Authors:  R S BERK
Journal:  J Bacteriol       Date:  1963-10       Impact factor: 3.490

10.  Independent functions of viral protein and nucleic acid in growth of bacteriophage.

Authors:  A D HERSHEY; M CHASE
Journal:  J Gen Physiol       Date:  1952-05       Impact factor: 4.086

View more
  4 in total

Review 1.  Ultrastructure of bacteriophage and bacteriocins.

Authors:  D E Bradley
Journal:  Bacteriol Rev       Date:  1967-12

2.  [The true nature of myxobacterial "rhapidosomes"].

Authors:  H Reichenbach
Journal:  Arch Mikrobiol       Date:  1967-04-17

3.  Bacteriophage DNA: correlation of buoyant density, melting temperature, and the chemically determined base composition.

Authors:  A M Kropinski
Journal:  J Virol       Date:  1974-03       Impact factor: 5.103

Review 4.  Bacteriophages of Myxococcus xanthus, a Social Bacterium.

Authors:  Marie Vasse; Sébastien Wielgoss
Journal:  Viruses       Date:  2018-07-18       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.